FONAR (NASDAQ:FONR – Get Free Report) issued its earnings results on Wednesday. The medical equipment provider reported $0.29 earnings per share for the quarter, Zacks reports. FONAR had a return on equity of 6.10% and a net margin of 9.41%.
FONAR Price Performance
Shares of FONR stock traded up $0.04 during mid-day trading on Wednesday, hitting $15.09. 10,686 shares of the stock traded hands, compared to its average volume of 14,628. The stock has a market cap of $95.49 million, a P/E ratio of 10.78 and a beta of 1.23. The stock’s fifty day moving average is $15.50 and its two-hundred day moving average is $15.99. FONAR has a 52-week low of $14.05 and a 52-week high of $24.05.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of FONAR from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th.
FONAR Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Further Reading
- Five stocks we like better than FONAR
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What to Know About Investing in Penny Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.
